A CRISP approach to QSP: XAI enabling fit-for-purpose models
Noah DeTal · 2025
Read A CRISP approach to QSP: XAI enabling fit-for-purpose models by Noah DeTal (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2505-02750.txt.
Introduction
Noah DeTal and colleagues shrink drug models to fit each use with explainable tools, in work from 2025. Systems pharmacology models promise faster drug growth and care shaped to each patient. Large models carry spare parameters that blur meaning and weaken forecast trust for key outputs.
Their workflow, called CRISP, starts with a broad model built from prior literature. A boundary method then trims the model while keeping core body paths intact. Trimming is tied to the exact forecast at hand, so cuts serve the question asked. Case studies cover blood clotting and a virus infection model in depth. Results flag paths to lift antibody therapy for HIV care.
Catalog record
| CREATOR | Noah DeTal |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 92 KB |
| VERSION | 1.0 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2505-02750
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
A CRISP approach to QSP: XAI enabling fit-for-purpose models Noah DeTal Abstract Abstract Quantitative Systems Pharmacology (QSP) promises to accelerate drug development, enable personalized medicine, and improve the predictability of clinical outcomes. Realizing this potential requires effectively managing the complexity of mathematical models representing biological systems. Here, we present and validate a novel QSP workflow–CRISP (Contextualized Reduction for Identifiability and Scientific Precision)–that addresses a central challenge in QSP: the problem of complexity and over-parameterization, in which models contain irrelevant parameters that obscure interpretation and hinder predictive reliability. The CRISP workflow begins with a literature-derived model, constructed to be comprehensive and unbiased by integrating prior mechanistic insights. At the core of the workflow is the Manifold Boundary Approximation Method (MBAM), a reduction technique that simplifies models while preserving mechanistic structure and predictive fidelity. By applying MBAM in a context-specific manner, CRISP links parsimonious models directly to predictions of interest, clarifying causal structure and enhancing interpretability. The resulting models are computationally efficient and well-suited to key QSP tasks, including virtual population generation, experimental design, toxicology, and target discovery. We demonstrate the utility of CRISP on case studies involving the coagulation cascade and SHIV infection, and identify promising directions for improving the efficacy of bNAb therapies for HIV. Together, these results establish CRISP as a general-purpose QSP workflow for turning complex mechanistic models into tools for precise scientific reasoning to guide pharmacological and regulatory decision-making. Author summary Quantitative Systems Pharmacology (QSP) uses mathematical models to understand complex biological systems and support drug development. However, these models are often so complex that they limit precise scientific reasoning. We introduce a new modeling workflow—CRISP (Contextualized Reduction for Identifiability and Scientific Precision)—designed to help scientists manage this complexity while improving the precision and reliability of QSP analyses. Starting from comprehensive models built from published research, CRISP uses automated tools to simplify models based on specific scientific questions, preserving their ability to make accurate predictions. This pipeline supports core QSP applications, including virtual population generation, experimental design, and target selection. We demonstrate CRISP using case studies in blood coagulation and SHIV infection. 1 Introduction Quantitative Systems Pharmacology (QSP) is an interdisciplinary field whose goals are to understand, predict, and control the behavior of complex biological systems [ 1 , 2 , 3 ] . Detailed mathematical and computational models are at the heart of the QSP approach that, distinct from traditional approaches to drug development, incorporates information about mechanisms to elucidate the biochemical foundation of drug efficacy, toxicity, and resistance at the system level. Such an approach incorporates diverse biological, pharmacological, and clinical data to create comprehensive models of drug action. These models promise to make predictions under novel conditions, accelerate and reduce risk in drug development, and inform patient-specific treatment decisions in personalized medicine [ 4 , 5 ] . Because the biochemical processes underlying pharmacology are complex, many of the challenges faced by QSP modelers are direct consequences of the complexity inherent in the systems themselves, including computational cost, numerical stability and conditioning, data requirements, and unidentifiable parameters. Consequently, there is no consensus workflow for building and validating QSP models [ 6 , 7 , 8 , 9 ] , with many recent reviews emphasizing the need for techniques to address these issues within a QSP framework [ 10 , 11 , 12 ] . In this paper, we present and validate a novel QSP workflow–CRISP (Contextualized Reduction for Identifiability and Scientific Precision)–that addresses a central challenge in QSP: the problem of complexity and over-parameterization, in which models contain irrelevant parameters that obscure interpretation and hinder predictive reliability. The pipeline is built on rigorous mathematical and deep philosophical foundations based on decades of careful research into the theory of predictive modeling using Information Geometry that endows researchers with an understanding of key mechanisms in their otherwise impenetrably complex systems. 1.1 Existing Approaches to Managing Model Complexity Effective strategies to address complexity in systems theory are informed by the modeling objectives. QSP models guide key decisions throughout the drug development process [ 4 ] , often making predictions under novel conditions for which experimental data are not available and for which the relevance of diverse biological mechanisms is not known. Consequently, complexity in QSP models tends to accumulate, often manifesting as a proliferation of unidentifiable parameters and plausible – but indistinguishable –mechanistic alternatives. It is widely recognized that effectively navigating complex models involves trade-offs between physical realism and parsimony [ 13 , 10 , 7 ] with parameter identifiability being a central issue [ 14 , 11 ] . Parameter identifiability analysis methods include those based on Fisher Information [ 15 , 11 ] and profile likelihood [ 16 , 15 ] , while ensembles of unidentifiable parameters may be represented in virtual populations [ 17 , 18 , 19 ] . A powerful approach involves rewriting the model parameters in terms of the identifiable combinations [ 20 ] . Experimental design methods can determine maximally informative experiments within the limitations of the model [ 21 , 22 , 23 , 24 ] . A range of model reduction strategies have been applied to QSP models, including lumping methods [ 25 , 26 ] , time-scale separation [ 27 , 28 ] , conservation analysis [ 29 ] , and control-theoretic techniques such as balanced truncation [ 30 , 31 ] . In this work, we use the Manifold Boundary Approximation Method (MBAM) as our model reduction scheme [ 32 ] . It systematically removes parameter combinations that have minimal influence on model outputs, but retains both the predictive fidelity and mechanistic interpretability of the original model. MBAM is unique among the above model reduction methods in that it does not assume a specific approximation structure a priori ; instead, it exploits the natural hierarchy of approximations intrinsic to the mathematical form of the model. In this way, it recovers many of the approximations produced by other methods automatically as special cases [ 32 , 33 , 34 , 35 ] based on information-theoretic criteria. This flexibility has traditionally come at a large computational cost. In this work, we leverage recent methodological advances that make MBAM applicable to large-scale QSP models. Sensitivity analysis methods are also widely used in QSP to assess how model parameters influence system behavior. Local sensitivity analysis (LSA), such as those based on the Fisher Information Matrix, are computationally efficient but can be misleading when sensitivity varies significantly across parameter space. Global sensitivity analysis (GSA) techniques—such as Sobol’ indices [ 36 , 37 ] , Fourier-based methods (e/FAST) [ 38 ] , and sampling-based approaches like Morris screening [ 39 ] —address this limitation by estimating parameter influence over a broad range of values, but they become prohibitively computationally expensive in high-dimensional models. Importantly, both LSA and GSA can obscure the mechanistic origins of the sensitivities they quantify. A model may appear insensitive to certain parameters for reasons that range from biologically meaningful to mathematically trivial. For example, if parameters are expressed in poorly scaled or unnatural units, both LSA and GSA may over- or under-estimate their importance. In contrast, Information Geometry analysis, described below, provides a coordinate-invariant framework for quantifying parameter importance based on the intrinsic geometry of the model manifold.